In this experiment, we used first specimens of the SCH tumor (HER2 IHC score 2+) because, in clinical specimens, those judged as HER2 IHC score 2+ are considered to be equivocal and the FISH test is recommended to make a final diagnosis for trastuzumab application. This evidence concerns the gene ERBB2 and neoplasm.